<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/63D85B81-69E5-4CF2-900F-79EC46CE32FC"><gtr:id>63D85B81-69E5-4CF2-900F-79EC46CE32FC</gtr:id><gtr:firstName>Hugh</gtr:firstName><gtr:otherNames>Joseph</gtr:otherNames><gtr:surname>Brady</gtr:surname><gtr:orcidId>0000-0002-3152-067X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901737"><gtr:id>3E99B1D3-72DC-4529-BF26-B1E6DD0D6A75</gtr:id><gtr:title>Delineating the genetic pathway of Natural Killer cell production</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901737</gtr:grantReference><gtr:abstractText>We have identified the master gene (E4bp4) that causes blood stem cells to turn into disease-fighting ?Natural Killer? (NK) immune cells. This discovery could one day help scientists boost the body?s production of these frontline tumour-killing cells, creating new ways to treat cancer and other diseases including those caused by viral or parasite infections. NK cells ? a type of white blood cell - are a major component of the human body s innate, quick-response immune system. They provide a fast frontline defence against tumours, viruses and bacterial infections, by scanning the human body for cells that are cancerous or infected with a virus or a bacterial pathogen and killing them. 
NK cells - along with all other types of blood cell, both white and red - are continuously generated from blood stem cells in the bone marrow over the course of a person?s lifetime. We would like to progress to a drug treatment for cancer patients which reacts with the protein expressed by their E4bp4 gene, causing their bodies to produce a higher number of NK cells than normal, to increase the chances of successfully destroying tumours. If increased numbers of the patient?s own blood stem cells could be coerced into differentiating into NK cells, via drug treatment, we would be able to bolster the body?s cancer-fighting force. This research proposal seeks to map out the genetic pathway controlled by the E4bp4 ?master gene?. If we know the components required to produce NK cells we may be able to use drugs to act selectively on one of those components to increase NK cell numbers and hence their disease fighting capability in sufferers.</gtr:abstractText><gtr:technicalSummary>Natural Killer (NK) cells are a distinct lineage of lymphocytes with both cytotoxic and cytokine (e.g. IFN-? and TNF) producing effector functions. NK cells play a central role in regulation of both the innate and adaptive immune response. They are associated with multiple functions and multiple pathologies such as cancer, microbial infections and autoimmune disease. In order to understand the basis of NK cell maturation and to manipulate NK cell numbers for therapeutic application, it is necessary to define the genetic pathway underlying NK cell development. We have recently identified the first gene, E4bp4, found to determine NK cell specific lineage determination (Gascoyne et al., 2009, Nature Immunology, published online Sept 13). By generating E4bp4-/- mice we showed that this gene is critical for NK cell development but not for NKT cells or CD8+ memory T cell production. There are no NK cells in the periphery of E4bp4-/- mice and the mice lack any detectable NK cell mediated cytotoxicity. E4bp4 has the remarkable ability to increase NK cell production when expressed in normal haematopoietic progenitors (HPCs), this highlights the possibility of manipulating NK cell numbers for therapeutic purposes. This research seeks to identify the genetic pathway used by E4bp4 to regulate NK cell production. DNA microarrays will be used to compare E4bp4-/- and +/+ HPCs to determine have their expression deregulated in the absence of E4bp4. Verification of targets will be carried out by real time PCR on -/- versus +/+ HPCs and wild type HPCs transduced by E4bp4. Chromatin immunoprecipitation will be used to define E4bp4 direct target genes. The functional of candidate target genes will be assessed by their retroviral-mediated overexpression and also shRNA-mediated knockdown in HPCs for readout by in vitro NK cell production assay. The function requirement of E4bp4 for the function and survival of mature NK cells (both mouse and human) will also be tested.</gtr:technicalSummary><gtr:fund><gtr:end>2013-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>508397</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Conference talk at NK2014 in Hannover</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9DC91DD2-DF77-4054-A2D5-51F27FE85E9D</gtr:id><gtr:impact>Talk led to multiple enquiries, new collaborations and opportunities for funding

Set up new collaboration with scientists from the Karolinska Institute, Stockholm and University of Oslo, Norway</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mh-hannover.de/fileadmin/kliniken/klinische_immunologie/download/NK-Cell-Symposium-2014-Program-Website.pdf</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DTG awarded to Imperial College (Biochemical Research)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>3184E422-6F9D-479D-ABD1-0874E70789BD</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/128AC691-7B15-4BDE-9C43-E811B0133935"><gtr:id>128AC691-7B15-4BDE-9C43-E811B0133935</gtr:id><gtr:title>E4BP4: an unexpected player in the immune response.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2bc2daade7204b0c32c705a148fed78"><gtr:id>e2bc2daade7204b0c32c705a148fed78</gtr:id><gtr:otherNames>Male V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6595BFAB-4EFA-45EF-9E68-A84C3CE156B2"><gtr:id>6595BFAB-4EFA-45EF-9E68-A84C3CE156B2</gtr:id><gtr:title>The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2bc2daade7204b0c32c705a148fed78"><gtr:id>e2bc2daade7204b0c32c705a148fed78</gtr:id><gtr:otherNames>Male V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9444120F-29A3-4217-9FE4-08BAEDC5C25B"><gtr:id>9444120F-29A3-4217-9FE4-08BAEDC5C25B</gtr:id><gtr:title>ILC Lineage Specification: To Be or Not 11b, That Is the Question.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0de0be7b2e919b358bfa624492fecb38"><gtr:id>0de0be7b2e919b358bfa624492fecb38</gtr:id><gtr:otherNames>Kostrzewski T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B5E49D9-AE4B-4A5A-A509-A417D29E9C0B"><gtr:id>8B5E49D9-AE4B-4A5A-A509-A417D29E9C0B</gtr:id><gtr:title>The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8d7c058fd7f6ebd1229979102230911"><gtr:id>a8d7c058fd7f6ebd1229979102230911</gtr:id><gtr:otherNames>Crotta S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/62C37960-BA25-4369-BF13-85373FD50DD9"><gtr:id>62C37960-BA25-4369-BF13-85373FD50DD9</gtr:id><gtr:title>Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59ba8c3310fdc0900f82494384e7c09d"><gtr:id>59ba8c3310fdc0900f82494384e7c09d</gtr:id><gtr:otherNames>Lee BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43D91435-C878-4E9C-9302-AC2748A04885"><gtr:id>43D91435-C878-4E9C-9302-AC2748A04885</gtr:id><gtr:title>Composition, Development, and Function of Uterine Innate Lymphoid Cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08566cf6ba91177d32e2e52ae20cccb5"><gtr:id>08566cf6ba91177d32e2e52ae20cccb5</gtr:id><gtr:otherNames>Doisne JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F44B6824-F7AD-41D2-8D49-4B1818DFB4A0"><gtr:id>F44B6824-F7AD-41D2-8D49-4B1818DFB4A0</gtr:id><gtr:title>The Residual Innate Lymphoid Cells in NFIL3-Deficient Mice Support Suboptimal Maternal Adaptations to Pregnancy.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdca1510c679d92f183b4bcce63c2b62"><gtr:id>bdca1510c679d92f183b4bcce63c2b62</gtr:id><gtr:otherNames>Boulenouar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A89BBAB8-BC5D-4658-9CF4-FA5B47C116B3"><gtr:id>A89BBAB8-BC5D-4658-9CF4-FA5B47C116B3</gtr:id><gtr:title>Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/190d2ef5ab79662df6a9ee04c70dc2c7"><gtr:id>190d2ef5ab79662df6a9ee04c70dc2c7</gtr:id><gtr:otherNames>Tong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B31F0B0-326D-4BAA-A959-DFE68BB3E46D"><gtr:id>2B31F0B0-326D-4BAA-A959-DFE68BB3E46D</gtr:id><gtr:title>Transcriptional control of natural killer cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59d2730ea04b11401c1f18023e0ec64f"><gtr:id>59d2730ea04b11401c1f18023e0ec64f</gtr:id><gtr:otherNames>Mart?n-Fontecha A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/384578CF-5199-42B0-95A5-00A7C3B90AC6"><gtr:id>384578CF-5199-42B0-95A5-00A7C3B90AC6</gtr:id><gtr:title>CD8a+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cac632793a8f04b476b943e8e9021ca5"><gtr:id>cac632793a8f04b476b943e8e9021ca5</gtr:id><gtr:otherNames>Seillet C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/124DE759-FBF0-465F-8EBB-85995874E070"><gtr:id>124DE759-FBF0-465F-8EBB-85995874E070</gtr:id><gtr:title>Differential requirement for Nfil3 during NK cell development.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cac632793a8f04b476b943e8e9021ca5"><gtr:id>cac632793a8f04b476b943e8e9021ca5</gtr:id><gtr:otherNames>Seillet C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BA2F5F9-E6A9-45BE-975E-82065CAEBC0B"><gtr:id>3BA2F5F9-E6A9-45BE-975E-82065CAEBC0B</gtr:id><gtr:title>Transcriptional control of NK cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2bc2daade7204b0c32c705a148fed78"><gtr:id>e2bc2daade7204b0c32c705a148fed78</gtr:id><gtr:otherNames>Male V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-3-319-07394-1</gtr:isbn><gtr:issn>0070-217X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA41586B-6B16-44D0-9ACF-680724825EEB"><gtr:id>BA41586B-6B16-44D0-9ACF-680724825EEB</gtr:id><gtr:title>NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e142474496bfae125798f6d29c9477e"><gtr:id>3e142474496bfae125798f6d29c9477e</gtr:id><gtr:otherNames>Xu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901737</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>